NFATc1 and NFATc3 Is Involved in the Expression of Receptor Activator of NF-κB Ligand in Activated T Lymphocytes
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Receptor activator of NF-κB ligand (RANKL) is an essential cytokine for osteoclast differentiation, activation and survival. T lymphocytes such as T17 cells, a subset of T helper cells that produce IL-17, play an important role in rheumatoid arthritic bone resorption by producing inflammatory cytokines and RANKL. It has not yet been clearly elucidated how T cell activation induces RANKL expression. T cell receptor activation induces the activation of nuclear factor of activated T cell (NFAT) and expression of its target genes. In this study, we examined the role of NFAT in T cell activation-induced RANKL expression. EL-4, a murine T lymphocytic cell line, was used. When T cell activation was induced by phorbol 12-myristate 13-acetate (PMA) and ionomycin,RANKL expression increased in a time-dependent manner. In the presence of cyclosporin, an inhibitor of NFAT activation, this PMA/ionomycin‐induced RANKL expression was blocked. Overexpression of either NFATc1 or NFATc3 induced RANKL expression. Chromatin immunoprecipitation results demonstrated that PMA/ionomycin treatment induced the binding of NFATc1 and NFATc3 to the mouse RANKL gene promoter. These results suggest that NFATc1 and NFATc3 mediates T cell receptor activationinduced RANKL expression in T lymphocytes.
Abstract
Receptor activator of NF-κB ligand (RANKL) is an essential cytokine for osteoclast differentiation, activation and survival. T lymphocytes such as T17 cells, a subset of T helper cells that produce IL-17, play an important role in rheumatoid arthritic bone resorption by producing inflammatory cytokines and RANKL. It has not yet been clearly elucidated how T cell activation induces RANKL expression. T cell receptor activation induces the activation of nuclear factor of activated T cell (NFAT) and expression of its target genes. In this study, we examined the role of NFAT in T cell activation-induced RANKL expression. EL-4, a murine T lymphocytic cell line, was used. When T cell activation was induced by phorbol 12-myristate 13-acetate (PMA) and ionomycin,RANKL expression increased in a time-dependent manner. In the presence of cyclosporin, an inhibitor of NFAT activation, this PMA/ionomycin‐induced RANKL expression was blocked. Overexpression of either NFATc1 or NFATc3 induced RANKL expression. Chromatin immunoprecipitation results demonstrated that PMA/ionomycin treatment induced the binding of NFATc1 and NFATc3 to the mouse RANKL gene promoter. These results suggest that NFATc1 and NFATc3 mediates T cell receptor activationinduced RANKL expression in T lymphocytes.
참고문헌 (29)
- Boyle WJ, "Osteoclast differentiation and activation", Nature, 423, pp.337~342 (2003)
- Walsh MC, "Osteoimmunology: interplay between the immune system and bone metabolism", Annu Rev Immunol, 24, pp.33~63 (2006)
- Nakashima T, "New regulation mechanisms of osteoclast differentiation", Ann N Y Acad Sci, 1240, pp.E13~E18 (2011)
- 전지혜, "Increase in Intracellular Calcium is Necessary for RANKL Induction by High Extracellular Calcium", International Journal of Oral Biology, 30(1), pp.9~16 (2005), 대한구강생물학회
- 이준원, "Negative regulators in RANKL-induced osteoclastogenesis", International Journal of Oral Biology, 32(1), pp.1~5 (2007), 대한구강생물학회
- Feske S, "Ca2+", calcineurin signalling in cells of the immune system, 2003, pp.311, 1117~1132
- Hogan PG, "Transcriptional regulation by calcium, calcineurin, and NFAT", Genes Dev, 17, pp.2205~2232 (2003)
- Oh-hora M, "The calcium", NFAT pathway: role in development and function of regulatory T cells, 2009, pp.11, 612~619
- Nakashima T, "Protein expression and functional difference of membrane-bound and soluble receptor activator of NF-kappaB ligand: modulation of the expression by osteotropic factors and cytokines", Biochem Biophys Res Commun, 275, pp.768~775 (2000)
- Theill LE, "RANK-L and RANK: T cells, bone loss, and mammalian evolution", Annu Rev Immunol, 20, pp.795~823 (2002)
- Takayanagi H, "Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems", Nat Rev Immunol, 7, pp.292~304 (2007)
- Rusnak F, "Calcineurin: form and function", Physiol Rev, 80, pp.1483~1521 (2000)
- Schulz RA, "Calcineurin signaling and NFAT activation in cardiovascular and skeletal muscle development", Dev Biol, 266, pp.1~16 (2004)
- Borel JF, "Biological effects of cyclosporin A: a new antilymphocytic agent", Agents Actions, 6, pp.468~475 (1976)
- Kino T, "FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro", J Antibiot (Tokyo), 40, pp.1256~1265 (1987)
- Okamoto K, "Regulation of bone by the adaptive immune system in arthritis", Arthritis Res Ther, 13, pp.219~ (2011)
- Horwood NJ, "Activated T lymphocytes support osteoclast formation in vitro", Biochem Biophys Res Commun, 265, pp.144~150 (1999)
- Kong YY, "Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand", Nature, 402, pp.304~309 (1999)
- Lubberts E, "IL-17 promotes bone erosion in murine collagen-induced arthritis through loss of the receptor activator of NF-kappa B ligand", osteoprotegerin balance, 2003, pp.170, 2655~2662
- Yuvaraj S, "A novel function of CXCL13 to stimulate RANK ligand expression in oral squamous cell carcinoma cells", Mol Cancer Res, 7, pp.1399~1407 (2009)
- Morgan AJ, "Ionomycin enhances Ca2+ influx by stimulating store-regulated cation entry and not by a direct action at the plasma membrane", Biochem J, 300, pp.665~672 (1994)
- Zhao Y, "Regulation of the alternative splicing of sarcoplasmic reticulum Ca²⁺ -ATPase1 (SERCA1) by phorbol 12-myristate 13-acetate (PMA) via a PKC pathway", Biochem Biophys Res Commun, 423, pp.212~217 (2012)
- Lee HL, "High extracellular calcium-induced NFATc3 regulates the expression of receptor activator of NF-kappaB ligand in osteoblasts", Bone, 49, pp.242~249 (2011)
- Boss V, "Induction of NFAT-mediated transcription by Gq-coupled receptors in lymphoid and non-lymphoid cells", J Biol Chem, 271, pp.10429~10432 (1996)
- Flanagan WM, "Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A", Nature, 352, pp.803~807 (1991)
- Liu J, "Calcineurin is a common target of cyclophilincyclosporin A and FKBP-FK506 complexes", Cell, 66, pp.807~815 (1991)
- O'Keefe SJ, "FK-506- and CsA-sensitive activation of the interleukin-2 promoter by calcineurin", Nature, 357, pp.692~694 (1992)
- Pinkas-Kramarski R, "Indications for selective coupling to phosphoinositide hydrolysis or to adenylate cyclase inhibition by endogenous muscarinic receptor subtypes M3 and M4 but not by M2 in tumor cell lines", Neurosci Lett, 108, pp.335~340 (1990)
- Okamoto K, "Osteoclasts in arthritis and Th17 cell development", Int Immunopharmacol, 11, pp.543~548 (2011)